Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down0.52% Nasdaq Down1.11%

PharmAthene, Inc. (PIP)

-NYSE MKT

1.64 Down 0.01(0.30%) 4:00PM EDT

Add to Portfolio
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.0
Mean Recommendation (last week):2.0
Change:0.0

* (Strong Buy) 1.0 - 5.0 (Sell)Compare to Industry

Price Target Summary
Mean Target:7.25
Median Target:7.25
High Target:8.50
Low Target:6.00
No. of Brokers:2

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Mar 5, 2013Aegis CapitalInitiated Buy
Jun 3, 2012Rodman & RenshawUpgradeMkt PerformMkt Outperform
Nov 27, 2011WBB SecuritiesDowngradeStrong BuyHold
Jan 3, 2011Rodman & RenshawDowngradeMkt PerformMkt Underperform
Oct 17, 2010WBB SecuritiesUpgradeBuyStrong Buy
Jul 22, 2010WBB SecuritiesUpgradeSpeculative BuyBuy
Feb 2, 2009Rodman & RenshawInitiated Mkt Outperform
Data provided by Briefing.com - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy0000
Buy2221
Hold0000
Underperform0000
Sell0000

Data provided by Thomson/First Call


Currency in USD.